Automated Oxygen Delivery in Neonatal Intensive Care.
Autor: | Nair V; Neonatal Intensive Care Unit, South Tees Hospitals National Health Service (NHS) Foundation Trust, James Cook University Hospital, Middlesbrough, United Kingdom.; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, United Kingdom., Loganathan P; Neonatal Intensive Care Unit, South Tees Hospitals National Health Service (NHS) Foundation Trust, James Cook University Hospital, Middlesbrough, United Kingdom., Lal MK; Neonatal Intensive Care Unit, South Tees Hospitals National Health Service (NHS) Foundation Trust, James Cook University Hospital, Middlesbrough, United Kingdom., Bachman T; School of Biomedical Engineering, Czech Technical University in Prague, Prague, Czechia. |
---|---|
Jazyk: | angličtina |
Zdroj: | Frontiers in pediatrics [Front Pediatr] 2022 Jun 22; Vol. 10, pp. 915312. Date of Electronic Publication: 2022 Jun 22 (Print Publication: 2022). |
DOI: | 10.3389/fped.2022.915312 |
Abstrakt: | Oxygen is the most common drug used in the neonatal intensive care. It has a narrow therapeutic range in preterm infants. Too high (hyperoxemia) or low oxygen (hypoxemia) is associated with adverse neonatal outcomes. It is not only prudent to maintain oxygen saturations in the target range, but also to avoid extremes of oxygen saturations. In routine practice when done manually by the staff, it is challenging to maintain oxygen saturations within the target range. Automatic control of oxygen delivery is now feasible and has shown to improve the time spent with in the target range of oxygen saturations. In addition, it also helps to avoid extremes of oxygen saturation. However, there are no studies that evaluated the clinical outcomes with automatic control of oxygen delivery. In this narrative review article, we aim to present the current evidence on automatic oxygen control and the future directions. Competing Interests: The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. (Copyright © 2022 Nair, Loganathan, Lal and Bachman.) |
Databáze: | MEDLINE |
Externí odkaz: |